Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 


Patients with family history of colorectal cancer may be at risk for aggressive form of the disease

When people with a family history of colorectal cancer develop the disease, their tumors often carry a molecular sign that the cancer could be life-threatening and may require aggressive treatment, Dana-Farber Cancer Institute scientists report in a new study.

The finding, reported in the Journal of the National Cancer Institute, draws on data from studies that have tracked the health of tens of thousands of people over several decades.

It suggests that colorectal cancer patients could one day have their tumor tissue tested for the molecular sign, and, if necessary, receive more powerful therapies and a familial cancer-risk assessment for their relatives. It further suggests that such patients' relatives could be eligible for more frequent colonoscopies to catch the disease at the earliest possible stage.

Unlike other abnormalities that raise the risk of colon cancer in some families, the newly discovered sign is not linked to a gene mutation that can be inherited from one's parents or grandparents. It appears in DNA segments that are thought to have entered the human genome millennia ago, possibly through infection by retroviruses. These sections, known as long interspersed nucleotide element 1 (LINE-1), are sprinkled throughout the human genome and make up about 17 percent of our DNA. Normally, LINE-1 doesn't cause much trouble, because it's blanketed by methyl groups (packets of one carbon atom bound to three hydrogen atoms).

In the current study, researchers led by Dana-Farber's Shuji Ogino, MD, PhD, MS, and Charles Fuchs, MD, MPH, found that for many colorectal cancer patients with a family history of the disease, the LINE-1 in their tumor cells was nearly bare of methyl groups (a condition known as hypomethylation).

"Previous studies have suggested that some colorectal cancers exhibit an instability of the epigenome, the cell's system for controlling when genes are active," says Ogino, the paper's first author. "One of the signs of this deficiency, it was proposed, is hypomethylation of LINE-1. We wanted to find whether a family history of colorectal cancer creates a higher risk of such hypomethylation."

Fuchs is the paper's senior author.

In contrast to a small, previous study, which suggested that LINE-1 hypomethylated colorectal cancers cluster in certain families, the new study took a large-scale "prospective" approach to gain more definitive insights. Investigators used data from the Nurses' Health Study and the Health Professionals Follow-up Study -- which follow the health of tens of thousands of people for decades -- to see if participants who had a family history of colorectal cancer tended to develop colorectal cancer with low-level methylation of LINE-1.

"We found that, compared to individuals without a family history of colorectal cancer, people who had first-degree relatives affected with the disease indeed had a higher risk of developing colorectal cancer with hypomethylated LINE-1," Ogino says. "Because this variety of colorectal cancer can quickly become dangerous, testing colorectal cancer patients for tumor LINE-1 hypomethylation may offer a valuable way of identifying those in greatest need of aggressive treatment. Such testing could also help identify patients whose relatives may be at increased risk for the aggressive form of the disease. Further study is needed to determine how this type of testing can be used in a clinical setting."

In addition to Ogino and Fuchs, the paper's co-authors are Reiko Nishihara, PhD, Paul Lochhead, MBChB, MRCP, Yu Imamura, MD, PhD, Aya Kuchiba, PhD, Teppei Morikawa, MD, PhD, Mai Yamauchi, PhD, Xiaoyun Liao, MD, PhD, Zhi Rong Qian, MD, PhD, Ruifang Sun, MB, Kaori Sato, MS, and Jeffrey Meyerhardt, MD, MPH, of Dana-Farber; Molin Wang, PhD, Donna Spiegelman, ScD, Eva S. Schernhammer, MD, DrPH, and Edward Giovannucci, MD, ScD, of the Harvard School of Public Health and BWH; Andrew T. Chan, MD, MPH, of BWH and Massachusetts General Hospital; and Gregory J. Kirkner, MPH, of BWH.

The study was funded in part by the National Institutes of Health (P01 CA87969, P01 CA55075, P50 CA127003, R01 CA151993, and R01 CA137178), the Bennett Family Fund for Targeted Therapies Research, and the National Colorectal Cancer Research Alliance.

Dana-Farber Cancer Institute is a principal teaching affiliate of the Harvard Medical School and is among the leading cancer research and care centers in the United States. It is a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC), designated a comprehensive cancer center by the National Cancer Institute. It provides adult care with Brigham and Women's Hospital as Dana-Farber/Brigham and Women's Cancer Center, and it provides pediatric care with Boston Children's Hospital as Dana-Farber/Children's Hospital Cancer Center. Dana-Farber is the top-ranked cancer center in New England, according to U.S. News & World Report, and one of the largest recipients among independent hospitals of National Cancer Institute and National Institutes of Health grant funding. Follow Dana-Farber on Twitter: @dana-farber or Facebook:

Bill Schaller | EurekAlert!
Further information:

More articles from Health and Medicine:

nachricht Inflammation Triggers Unsustainable Immune Response to Chronic Viral Infection
24.10.2016 | Universität Basel

nachricht Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Magnete aus dem 3D-Drucker

Wie kann man einen Magneten bauen, der genau das gewünschte Magnetfeld hat? Die TU Wien hat eine Lösung: Erstmals können Magnete mit 3D-Drucker hergestellt werden.

Starke Magnete herzustellen ist heute technisch kein Problem. Schwierig ist es allerdings, einen Permanentmagneten zu produzieren, dessen Magnetfeld eine ganz...

Im Focus: Die Quanten-Schnüffelnase

Der Laser, der zugleich ein Detektor ist: An der TU Wien wurde ein mikroskopisch kleiner Sensor entwickelt, mit dem man gleichzeitig verschiedene Gase nachweisen kann.

Wir Menschen erschnüffeln unterschiedliche Gerüche und Düfte durch chemische Rezeptoren in unserer Nase. Doch für den technischen Nachweis von Gasen greift man...

Im Focus: „Molekül-Selfie“ enthüllt den Aufbruch einer chemischen Bindung

Wissenschaftlern des Institute of Photonic Sciences (Barcelona) ist es gelungen, die Position aller Atome eines Moleküls zu verfolgen während der Aufbruch einer der chemischen Bindungen ein einzelnes Proton freisetzt. Hierzu wurde ein am Heidelberger Max-Planck-Institut für Kernphysik entwickeltes Reaktionsmikroskop verwendet [Science, 21. Oktober 2016].

Man stelle sich vor, die einzelnen Atome eines Moleküls ließen sich während einer chemischen Reaktion beobachten: Wie sie sich umlagern, um eine neue Substanz...

Im Focus: Elektronik mit Licht beschleunigen

Wissenschaftler am MPQ haben mit ultrakurzen Laserpulsen die schnellsten jemals erzeugten elektrischen Ströme in Festkörpern gemessen. Die Elektronen führten in einer Sekunde achtmillionen Milliarden Schwingungen aus, ein absoluter Rekord für die Steuerung von Elektronen in Festkörpern.

Die Leistungsfähigkeit von modernen elektronischen Geräten wie Computern oder Mobilfunkgeräten wird durch die Geschwindigkeit bestimmt, mit der die...

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Alle Focus-News des Innovations-reports >>>



im innovations-report
in Kooperation mit academics

Großer Hirntumor-Informationstag in Würzburg

24.10.2016 | Veranstaltungen

Führende Rohstoffwissenschaftler stellen auf BMBF-Statuskonferenz ihre r⁴-Forschungsarbeiten vor

24.10.2016 | Veranstaltungen

Futurium startet mit Pop-Up-Lab das Satellitenprogramm des STATE-Festivals

24.10.2016 | Veranstaltungen

Weitere VideoLinks >>>
Aktuelle Beiträge

Großer Hirntumor-Informationstag in Würzburg

24.10.2016 | Veranstaltungsnachrichten

Führende Rohstoffwissenschaftler stellen auf BMBF-Statuskonferenz ihre r⁴-Forschungsarbeiten vor

24.10.2016 | Veranstaltungsnachrichten

Lange gesucht, endlich gefunden: Die rostfressende Mikrobe

24.10.2016 | Biowissenschaften Chemie